Rick Lesniewski
Impact in
-
- Protease and Inhibitor Mechanisms
- Oncology top 10%
- Peptidase Inhibition and Analysis
- Cancer Treatment and Pharmacology
Papers in
- Oncology 7
- Peptidase Inhibition and Analysis 4
- Vascular Tumors and Angiosarcomas 1
-
- Protease and Inhibitor Mechanisms 2
- Co-authors
- Jack HenkinPingping LouJieyi WangDavid A. EganAndrew J. SchneiderDimitri SemizarovDonald J. DavidsonCatherine J. Haskell
- Journals
- Molecular Cancer Therapeutics (2 papers)Molecular Cancer Research (1 paper)Clinical Cancer Research (1 paper)Journal of Proteome Research (1 paper)European Journal of Cancer (1 paper)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Rick Lesniewski
10 papers receiving 643 citations
Peers
Comparison fields: 5 of 82
- Cancer Research 151
- Oncology 261
- Cell Biology 129
- Molecular Biology 395
- Immunology and Allergy 20
Countries citing papers authored by Rick Lesniewski
This map shows the geographic impact of Rick Lesniewski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rick Lesniewski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rick Lesniewski more than expected).
Fields of papers citing papers by Rick Lesniewski
This network shows the impact of papers produced by Rick Lesniewski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rick Lesniewski. The network helps show where Rick Lesniewski may publish in the future.
Co-authors
The 25 scholars most cited alongside Rick Lesniewski, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 44 | |
| 2 | 2010 | 5 | |
| 3 | 2008 | 41 | |
| 4 | 2008 | 19 | |
| 5 | 2007 | 53 | |
| 6 | 2007 | 33 | |
| 7 | Characterization of human circulating endothelial cells to monitor response to antitumor therapy in human clinical trials | 2006 | 1 |
| 8 | 2005 | 194 | |
| 9 | 2003 | 170 | |
| 10 | 2003 | 89 |
About Rick Lesniewski
Rick Lesniewski is a scholar working on Oncology, Cancer Research, Molecular Biology, Hepatology and Cellular and Molecular Neuroscience, having authored 10 papers that have together received 649 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (4 papers), Signaling Pathways in Disease (3 papers), Angiogenesis and VEGF in Cancer (3 papers), Protease and Inhibitor Mechanisms (2 papers), Neuropeptides and Animal Physiology (2 papers), Glycosylation and Glycoproteins Research (1 paper), Vascular Tumors and Angiosarcomas (1 paper) and Cell death mechanisms and regulation (1 paper). The work is most often cited by research in Cancer Research (151 citations), Oncology (261 citations), Cell Biology (129 citations), Molecular Biology (395 citations) and Immunology and Allergy (20 citations). Rick Lesniewski has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Jack Henkin, Pingping Lou, Jieyi Wang, David A. Egan, Andrew J. Schneider, Dimitri Semizarov, Donald J. Davidson, Catherine J. Haskell, Zhebo Chen and Karl A. Walter. Their work appears in journals such as Molecular Cancer Therapeutics, Molecular Cancer Research, Clinical Cancer Research, Journal of Proteome Research and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.